Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.
Singapore, London, 05 September 2019: Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.
Mayo spent 21 years with Ogilvy and WPP, later as CEO of Ogilvy Asia, working with brands including Diageo, Coca-Cola, Motorola, Nike, Nestle, Huawei and Mondelez.
He also founded his own agency, RedCard, taking it from a one-person operation to a global company with offices across five countries, within five years. During his time at the company, David worked with brands including The Economist, Nike, BBC, Burger King, Motorola and Gillette. Ogilvy subsequently acquired RedCard in 2006.
Mayo has extensive knowledge of the MedTech sector. He currently serves as CMO and Non-Executive Director of BetaMedTech, a Singapore-based healthcare development company backed by SINGAPORE A-Star grants and funding, which has developed a technology that predicts and prevents the onset of pressure ulcers, a medical injury that costs the US Health Department $11bn and the UK National Health Service £450m a year.
With a strong background in strategy, brands and operational systems, Mayo will be tasked with ensuring that the core business pillars of Verita Healthcare Group – Services, Products and Technology – are integrated and supported by strategic brand management, digital marketing and end-to-end sales systems to support the growth of the company.
Founded in 2015, Verita Healthcare Group integrates preventative, precision treatments and products with the power of MedTech, Analytics and AI.
Together with the company’s fast diagnostics and digital health management technologies, a wide range of evidence-based treatment products and its growing number of specialised centres around the world, Verita creates a single platform for precise, preventative, patient-centric healthcare.
Julian Andriesz, Founder and Group Chairman of Verita Health Group said: “Through our “Incubate, Innovate, Integrate” strategy, Verita’s growth is accelerating rapidly, with over 20 operating companies across four continents.
“In order to harness our full potential, we need agile minds, clear vision and bold strategies to ensure that we deliver the promise of fully integrative healthcare. David has proven his strength in these and several other critical areas early in his career and I am very pleased to have him join our senior management team in leading Sales and Marketing.”
Mayo added: “Having spent the first half of my working life in Advertising, I now want to spend the second half working in a sector with a company that gives back in a meaningful way. Disruption is everywhere but none more so than in the global health economy. The combination of increasing diseases, a growing population and a global healthcare system that is still focused on reactive sickness management instead of proactive healthcare, creates a perfect space for this disruption.
“The global healthcare market is predicted to grow to around $10tn by 2022 and it represents a significant proportion of global GDP, so it’s a good time to be disrupting rather than defending! With its global reach and strong leadership reputation, Verita is an exciting, challenging place to do that from.”
Mayo starts immediately.
Enquiries:
Yellow Jersey PR
Georgina Whittle: +44(0)7835 770967
Alex Crean: +44(0)7753 170777
About Verita Healthcare Group
Verita is a global healthcare group that combines science and nature to prevent and fight disease. It harnesses proprietary research, manufacturing, and specialist treatment to enhance the body’s own natural performance. The company’s patient centric model is designed to meet a growing demand for smarter healthcare that focuses on proactive wellness rather than reactive treatment; evidence-based disease prevention; and life extension.
Founded in Singapore, with European headquarters in London, Verita is built on 12 years of research and development. Its board members are leaders of global institutions, including Founder Julian Andriesz, President of the Cancer-Aid Foundation in Switzerland; and Senior Advisor Prof. Dr. Bernd Kleine-Gunk, President of the German Society of Anti-Aging Medicine (GSAAM).
The Group operates treatment clinics, in-house product development and manufacturing, a comprehensive data analytics MedTech platform and an international R&D network. It operates globally from facilities in North America, Asia and Europe.
Verita collaborates with some of the world’s most advanced research and medical institutions to treat referred patients, co-develop new protocols and treatments, and explore advances in integrative healthcare. Partners include the Massachusetts Institute of Technology (MIT), Harvard Medical School and the Australian National University.
In the UK, Verita is the only medical app approved by the National Health Service (NHS) for the treatment of diabetes.
